Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

NCT05798897

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +18 more
Locations
  • City of Hope Duarte, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Colorado Blood Cancer Institute (Sarah Cannon) Denver, Colorado, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
View Trial Details
Recruiting

Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma

NCT05998642

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
  • BCCA - Vancouver Vancouver, British Columbia, Canada
  • Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
  • Ottawa Hospital Research Institute Ottawa, Ontario, Canada
View Trial Details
Recruiting

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

NCT06976476

Conditions
Agammaglobulinemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activity) Commack, New York, United States
View Trial Details
Recruiting

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

NCT07195916

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +29 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • The University of Nebraska Medical Center Omaha, Nebraska, United States
View all 22 locations
View Trial Details
Recruiting

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

NCT07003100

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +19 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
View Trial Details

Related conditions